Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-07-057114
Filing Date
2007-10-30
Accepted
2007-10-30 16:30:50
Documents
11

Document Format Files

Seq Description Document Type Size
1 v091670_f3.htm F-3 727971
2 GRAPHIC pwclogo.jpg GRAPHIC 6689
3 GRAPHIC xtllogo.jpg GRAPHIC 2737
4 v091670_ex1-1.htm EX-1.1 244995
5 v091670_ex1-2.htm EX-1.2 124642
6 v091670_ex1-3.htm EX-1.3 90037
7 GRAPHIC logo.jpg GRAPHIC 86404
8 v091670_ex5-1.htm EX-5.1 18238
9 v091670_ex23-2.htm EX-23.2 5342
10 v091670_ex23-3.htm EX-23.3 6401
11 v091670_ex23-4.htm EX-23.4 7506
  Complete submission text file 0001144204-07-057114.txt   1358931
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: F-3 | Act: 33 | File No.: 333-147024 | Film No.: 071199954
SIC: 2834 Pharmaceutical Preparations